---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-22-000428"
form_type: "8-K"
ticker: "DRMA"
cik: "0001853816"
company_name: "Dermata Therapeutics, Inc."
filed_at: "2022-01-13T23:59:59+00:00"
generated_at: "2026-06-27T18:23:57.256094+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Dermata appoints Brittany Bradrick to Board and Audit Committee

## Summary
- Board expanded from 7 to 8; Bradrick appointed as Class II director effective Jan 12, 2022.
- Bradrick brings over 25 years life science finance/strategy experience; currently CFO of Neurelis.
- Received option to purchase 10,000 shares at $1.50, vesting monthly over 12 months.
- Dr. Steven Mento steps down from Audit Committee but stays on Board and Nominating Committee.
- No family relationships or transactions requiring disclosure with other officers/directors.

## SEC filing metadata
- accession: 0001654954-22-000428
- form_type: 8-K
- ticker: DRMA
- cik: 0001853816
- company_name: Dermata Therapeutics, Inc.
- filed_at: 2022-01-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1853816/000165495422000428/0001654954-22-000428-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1853816/000165495422000428/drma_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-22-000428
- JSON: https://secwatch.observer/filing/0001654954-22-000428.json
- Plain text: https://secwatch.observer/filing/0001654954-22-000428.txt

## Key facts
- Executive change
  Brittany Bradrick was appointed as Director at Dermata Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: the Board increased its size from seven to eight directors and appointed Brittany Bradrick as a Class II director to fill the newly created vacancy.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1853816/000165495422000428/0001654954-22-000428-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.